Infection Control News

Reusing single-use surgical masks for up to a week had no major impact on skin or upper respiratory tract microbiomes, according to data published in The Journal of Infectious Diseases.

An FDA advisory committee on Thursday voted in favor of approving the long-acting monoclonal antibody nirsevimab to protect neonates and infants from respiratory syncytial virus.

Antimicrobial stewardship interventions recommended by either female or male clinicians were equally accepted, according to a recent study.

A study of almost 4,000 people with HIV and sustained 2-year period of viral suppression found that they were unlikely to experience viral rebound over the next 2 years, supporting treatment as prevention as an HIV prevention strategy.

A review of nearly 250,000 doses of messenger RNA COVID-19 vaccine administered to young children identified no serious side effects from the shots, according to results published in Pediatrics.

The FDA on Tuesday approved letermovir for the prevention of cytomegalovirus disease in high-risk adult kidney transplant recipients, Merck announced.

The FDA has recently approved Pfizer’s respiratory syncytial virus vaccine, branded as Abrysvo, for adults aged 60 years or older.

Transplant medicine and the field of transplant infectious diseases have faced numerous disruptions and challenges during the COVID-19 pandemic, according to experts.

Among more than 72,000 blood donors in the United States aged 16 years or older, 96% had antibodies against the virus that causes COVID-19 by late last year, according to a new analysis.

The FDA this week approved Pfizer’s respiratory syncytial virus vaccine for adults aged 60 years or older — the second RSV vaccine approved for this population in the last month.